Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.

AbstractObjectiveThe efficacy and safety of low-dose paroxetine 7.5 mg for the treatment of menopausal vasomotor symptoms were evaluated in two multicenter, double-blind, placebo-controlled, phase 3 studies of 12 and 24 weeks’ duration.MethodsPostmenopausal women were randomly assigned 1:1 to receiv